Clinical Trial Update: A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Siliphos in adults with fatty liver (NASH) completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Siliphos

Snippet

Sponsor: Heather Patton | Conditions: Fatty Liver | Phase 2 | Status: COMPLETED | Results posted: 2021-03-24